Statistics for Use of sibutramine (Meridia) in obese patients with Type 2 diabetes is associated with statistically significant weight loss and a decreased hemoglobin A1c

Total visits

views
Use of sibutramine (Meridia) in obese patients with Type 2 diabetes is associated with statistically significant weight loss and a decreased hemoglobin A1c 86

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

File Visits

views
Sandvig-PET.pdf 131

Top country views

views
United States 41
China 11
Germany 7
France 6
Brazil 3
Ireland 3
Israel 2
Russia 2
Singapore 2
Australia 1
Canada 1
United Kingdom 1
Hong Kong SAR China 1
Indonesia 1
South Korea 1
Netherlands 1
Senegal 1

Top city views

views
Buffalo 6
Ashburn 5
Des Moines 3
Dublin 3
Mountain View 3
Shenzhen 3
Brooklyn 2
Cheyenne 2
Los Angeles 2
Saint Petersburg 2
Singapore 2
Beijing 1
Dakar 1
Dongguan 1
Fort Worth 1
Fremont 1
Jakarta 1
Lincoln 1
Maragogi 1
Melbourne 1
New York 1
Oak Brook 1
Oakland 1
Old Bridge 1
Phoenix 1
Recife 1
Rio de Janeiro 1
Shanghai 1
Sioux Falls 1
Southend 1
Staten Island 1
Tel Aviv 1
Toronto 1
Walnut 1
Zhengzhou 1